Clinic
Steward Texas Hospital Holdings LLC
Steward Texas Hospital Holdings LLC was paid $5.10M by Medicaid between Sep 2019 and Nov 2024, across 41 billing codes. Its largest line is 99284, emergency room visit (serious) — 46% of everything it billed.
33Billing provider infoSTEWARD TEXAS HOSPITAL HOLDINGS LLC
BIG SPRING, TX 79720
BIG SPRING, TX 79720
33aNPI1285191452assigned 02/25/2019
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$5.10M
24GClaims24,500
24DCodes billed41
24AFirst – last monthSep 2019 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#76 of 320
Median peer was paid$205K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 367 | $45K | |
| 2020 | 622 | $49K | |
| 2021 | 6,013 | $850K | |
| 2022 | 6,566 | $1.64M | |
| 2023 | 7,281 | $1.90M | |
| 2024incomplete | 3,651 | $619K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 46% | 3,437 | 3,275 | $2.33M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 38% | 4,910 | 4,745 | $1.93M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.6% | 378 | 344 | $285K |
| G0378 | Hospital observation service, per hour | 3.0% | 287 | 112 | $154K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 1,905 | 937 | $73K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.1% | 155 | 148 | $58K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.0% | 1,213 | 1,170 | $53K |
| 71045 | Radiologic examination, chest; single view | <1% | 405 | 377 | $48K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 599 | 581 | $43K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 27 | 25 | $25K |
| 80053 | Comprehensive metabolic panel | <1% | 2,252 | 2,008 | $25K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,200 | 3,622 | $16K |
29 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 477 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,867 | $15K |
| 87807 | <1% | 177 | $5K | |
| 87081 | <1% | 306 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 154 | $4K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 167 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 125 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 46 | $2K |
| 81001 | <1% | 362 | $2K | |
| 85027 | <1% | 197 | $2K | |
| 86141 | <1% | 46 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 115 | $1K |
| 86710 | <1% | 76 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 20 | $897.43 |
| 85007 | <1% | 134 | $754.35 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 13 | $541.82 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 33 | $508.99 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 44 | $405.12 |
| 83690 | <1% | 24 | $325.44 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 14 | $297.08 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 36 | $245.40 |
| 87040 | <1% | 12 | $229.68 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $54.74 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14 | $46.38 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 42 | $41.23 |
| 81003 | <1% | 13 | $13.15 | |
| 80061 | Lipid panel | 0% | 12 | $0.00 |
| A9270 | Non-covered item or service | 0% | 164 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKRABILL, EMMA (CEO)